Judy D. Olian is Director at UNITED THERAPEUTICS Corp (UTHR). They have made 19 open-market trades across 2 companies since 2014, most recently 2026-07-30.
CIK 0001605729
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $90K since 2014, against 17 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ARES | 31,462 | $3.5M |
| UTHR | 5,555 | $3.0M |
| MAT | 59,298 | $1.0M |
| Total | $7.5M |
Shares reported on the most recent Form 4, priced at the 2026-08-03 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| UTHR | SELL · 10b5-1 | 2026-03-23 | 2026-03-24 | $530.00 | $106K | +4.2% | +6.7% | +0.2% |
| UTHR | SELL | 2026-03-16 | 2026-03-16 | $535.44 | $107K | -0.2% | +8.3% | +2.9% |
| UTHR | SELL · 10b5-1 | 2026-03-06 | 2026-03-09 | $510.00 | $102K | +0.2% | +10.6% | +3.6% |
| UTHR | SELL · 10b5-1 | 2026-02-27 | 2026-03-02 | $509.55 | $102K | +4.6% | +12.0% | +7.0% |
| ARES | BUY | 2026-02-20 | 2026-02-24 | $124.43 | $60K | -7.4% | -9.0% | +5.5% |
| UTHR | SELL | 2025-09-19 | 2025-09-19 | $415.43 | $748K | +4.5% | +3.2% | +20.9% |
| UTHR | SELL | 2024-11-11 | 2024-11-12 | $412.48 | $722K | -6.8% | -9.6% | -13.6% |
| UTHR | SELL | 2024-06-17 | 2024-06-18 | $295.43 | $502K | +4.3% | +7.5% | +12.8% |
| ARES | SELL | 2024-06-07 | 2024-06-10 | $134.00 | $458K | -3.4% | +1.6% | +2.6% |
| UTHR | SELL | 2024-05-03 | 2024-05-06 | $258.54 | $5.1M | +4.1% | +5.9% | +24.6% |
| UTHR | SELL | 2024-03-12 | 2024-03-13 | $248.07 | $1.4M | +1.7% | -3.1% | +14.8% |
| ARES | SELL | 2023-05-23 | 2023-05-25 | $85.59 | $103K | +6.9% | +8.3% | +17.6% |
| UTHR | SELL | 2023-01-03 | 2023-01-03 | $276.26 | $318K | -4.2% | -4.8% | -17.3% |
| UTHR | SELL | 2022-12-09 | 2022-12-09 | $282.00 | $285K | -2.0% | -5.1% | -19.4% |
| UTHR | SELL | 2022-11-08 | 2022-11-08 | $265.09 | $318K | +0.8% | +6.6% | -2.8% |
| UTHR | SELL | 2022-06-27 | 2022-06-28 | $240.34 | $2.4M | +2.8% | -2.2% | -13.5% |
| UTHR | SELL | 2022-05-26 | 2022-05-26 | $226.46 | $2.3M | +1.2% | +6.6% | -1.6% |
| UTHR | SELL | 2021-04-01 | 2021-04-02 | $184.96 | $1.6M | +5.4% | +4.9% | -4.0% |
| UTHR | SELL | 2021-03-17 | 2021-03-19 | $170.00 | $358K | -1.1% | +20.5% | +7.9% |
| UTHR | SELL | 2020-06-08 | 2020-06-08 | $124.96 | $1.1M | -7.3% | -5.6% | -17.7% |
| UTHR | SELL | 2018-06-12 | 2018-06-13 | $112.38 | $67K | +0.6% | +10.5% | +8.0% |
| ARES | BUY | 2014-12-05 | 2014-12-08 | $16.69 | $30K | -9.9% | +0.6% | +0.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.